Viking Therapeutics Inc (USD)
VKTX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range6.52 | 6.81
52-Wk Range6.10 | 11.03
Last Close6.73
Mkt Cap (m)486.33
Dividend yield-
ISINUS92686J1060
Volume1,063,681
Exchange VenueNAS

Company Profile

Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.

Key Information
Price/Earning-
Price/Book1.72
Price/Sales-
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 02/08/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201420152016201720182019
Revenue (m)-
Operating Income (m)-23-12-14-19-26-
Net Income (m)-22-23-15-21-22-
Basic EPS-7.03-3.68-0.90-0.79-0.38-
Avg. Diluted Shares Outstanding (m)46162658-
Balance Sheet
USD201420152016201720182019
Current Assets (m)1151422302-
Non Current Assets (m)21-
Total Assets (m)3151522302-
Current Liabilities (m)232695-
Total Liabilities (m)------
Total Equity (m)-229813298-
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-2-9-11-15-19-
Capital Expenditure (m)------
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
6.73
Last Price